(Q53547058)

English

Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

portal hypertension

1 reference

based on heuristic

inferred from title

author name string

Chuan-Tao Tu

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

Jin-Sheng Guo

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

Manner Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

Ji-Yao Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

22

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

877-884

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

Complications of cirrhosis. I. Portal hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Vascular mediators in the injured liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Eicosanoids in cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Pathogenesis of fibrosis: role of TGF-beta and CTGF.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Cyclooxygenase-2: a therapeutic target in angiogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Antiangiogenic effect of a highly selective cyclooxygenase-2 inhibitor on gastric ulcer healing in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Transforming growth factor-beta1 stimulates the synthesis of basement membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

The chemokine receptor CCR1 is strongly up-regulated after skin injury but dispensable for wound healing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Eicosanoid-mediated contractility of hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2007.04867.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2007.04867.X

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/17565644

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53547058&oldid=1711061212"